ADMA - ADMA BIOLOGICS, INC.
16.54
0.160 0.967%
Share volume: 8,245,421
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$16.38
0.16
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-18-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-25-2026 | |
| Cash flow financing | -1.447 M | -362.000 K | -25.467 M | -31.026 M | -7.127 M | 48.000 K | -27.825 M | -9.118 M | |
| Other financing cash flows | -1.447 M | -362.000 K | 4.533 M | -576.000 K | -7.127 M | 498.000 K | -1.513 M | 266.000 K | |
| Cash flow | -6.027 M | 42.919 M | -1.537 M | 16.440 M | -31.522 M | 18.660 M | -28.900 M | 26.245 M | |
| Net income | 17.806 M | 32.062 M | 35.909 M | 111.896 M | 26.904 M | 34.219 M | 36.428 M | 49.379 M | |
| Depreciation | 2.114 M | 2.047 M | 1.940 M | 1.944 M | 1.969 M | 2.058 M | 2.023 M | 2.046 M | |
| Changes in inventories | 4.826 M | 0.000 | 0.000 | 0.000 | 1.953 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -2.362 M | -2.365 M | -1.098 M | -2.750 M | -4.720 M | -2.527 M | -14.368 M | -276.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 2.347 M | 2.066 M | 1.056 M | 2.757 M | 4.701 M | 2.422 M | 14.368 M | 1.084 M | |
| Cash Change | -6.027 M | 42.919 M | -1.537 M | 16.440 M | -31.522 M | 18.660 M | -28.900 M | 26.245 M |